{"id":{"repo_id":"sdstate","oai_identifier":"oai:openprairie.sdstate.edu:etd2-2253"},"canonical_url":"https://search.ndltd.org/etd/sdstate/oai:openprairie.sdstate.edu:etd2-2253","repository":{"repo_id":"sdstate","name":"South Dakota State University","base_url":"https://openprairie.sdstate.edu/do/oai/"},"display":{"title":"Immunogenicity and Protection Efficacy of a Herpes Simplex Virus-based Amplicon Vector Expressing Codon-optimized Glycoprotein 5 of PRRSV","abstract":"In previous studies, we have shown that plasmid DNA priming followed by boosting with a herpes simplex virus (HSV)-1 amplicon vectored human immunodeficiency virus (HIV)-1 gp120 antigen induced potent T cell-mediated immunity and antibody response in immunized mice. To evaluate the potential application of this immunotherapeutic approach for porcine reproductive and respiratory syndrome virus (PRRSV) vaccine development, we generated plasmid DNA and a HSV-1 amplicon vector encoding codon-optimized glycoprotein 5 (sGP5) gene of PRRSV. The immunogenicity and protection efficacy of these constructs were evaluated in pigs. Results showed that sGp5 specific, interferon-gamma secreting CD4 T cells and antibody responses were induced via the DNA prime/amplicon boost regimen. Increases in CD4 T cell immunity and antibody responses were observed following challenge of animals with PRRSV, indicative of a memory immune response elicited by the vaccination. However, no PRRSV-specific neutralization (VN) antibody was detected after the boosting immunization, although a subset of animals developed VN antibody following virus challenge with titers ranging from 1 :4 to l: 16. Furthermore, viral RNA was detected in the sera of all animals at 10 days after challenge. Overall, HSV-1 amplicon-vectored PRRSV sGp5 induced PRRSV-specific T cell and antibody responses in immunized animals, but such immune responses were insufficient to provide protection against viremia of animals after PRRSV challenge.","abstract_html":"In previous studies, we have shown that plasmid DNA priming followed by boosting with a herpes simplex virus (HSV)-1 amplicon vectored human immunodeficiency virus (HIV)-1 gp120 antigen induced potent T cell-mediated immunity and antibody response in immunized mice. To evaluate the potential application of this immunotherapeutic approach for porcine reproductive and respiratory syndrome virus (PRRSV) vaccine development, we generated plasmid DNA and a HSV-1 amplicon vector encoding codon-optimized glycoprotein 5 (sGP5) gene of PRRSV. The immunogenicity and protection efficacy of these constructs were evaluated in pigs. Results showed that sGp5 specific, interferon-gamma secreting CD4 T cells and antibody responses were induced via the DNA prime/amplicon boost regimen. Increases in CD4 T cell immunity and antibody responses were observed following challenge of animals with PRRSV, indicative of a memory immune response elicited by the vaccination. However, no PRRSV-specific neutralization (VN) antibody was detected after the boosting immunization, although a subset of animals developed VN antibody following virus challenge with titers ranging from 1 :4 to l: 16. Furthermore, viral RNA was detected in the sera of all animals at 10 days after challenge. Overall, HSV-1 amplicon-vectored PRRSV sGp5 induced PRRSV-specific T cell and antibody responses in immunized animals, but such immune responses were insufficient to provide protection against viremia of animals after PRRSV challenge.","abstract_has_math":false,"creators":["Eaton, Michael"],"institution":null,"degree_name":"Master of Science (MS)","degree_level":"Thesis - University Access Only","degree_discipline":"Biology and Microbiology","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T09:04:49Z","subjects":[],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://openprairie.sdstate.edu/etd2/1248","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://openprairie.sdstate.edu/etd2/1248","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://openprairie.sdstate.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Aopenprairie.sdstate.edu%3Aetd2-2253","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Eaton, Michael"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2024-11-08T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2006-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biology and Microbiology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis - University Access Only"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (MS)"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://openprairie.sdstate.edu/etd2/1248"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["In previous studies, we have shown that plasmid DNA priming followed by boosting with a herpes simplex virus (HSV)-1 amplicon vectored human immunodeficiency virus (HIV)-1 gp120 antigen induced potent T cell-mediated immunity and antibody response in immunized mice. To evaluate the potential application of this immunotherapeutic approach for porcine reproductive and respiratory syndrome virus (PRRSV) vaccine development, we generated plasmid DNA and a HSV-1 amplicon vector encoding codon-optimized glycoprotein 5 (sGP5) gene of PRRSV. The immunogenicity and protection efficacy of these constructs were evaluated in pigs. Results showed that sGp5 specific, interferon-gamma secreting CD4 T cells and antibody responses were induced via the DNA prime/amplicon boost regimen. Increases in CD4 T cell immunity and antibody responses were observed following challenge of animals with PRRSV, indicative of a memory immune response elicited by the vaccination. However, no PRRSV-specific neutralization (VN) antibody was detected after the boosting immunization, although a subset of animals developed VN antibody following virus challenge with titers ranging from 1 :4 to l: 16. Furthermore, viral RNA was detected in the sera of all animals at 10 days after challenge. Overall, HSV-1 amplicon-vectored PRRSV sGp5 induced PRRSV-specific T cell and antibody responses in immunized animals, but such immune responses were insufficient to provide protection against viremia of animals after PRRSV challenge."]},{"key":"dc:title","label":"Title","values":["Immunogenicity and Protection Efficacy of a Herpes Simplex Virus-based Amplicon Vector Expressing Codon-optimized Glycoprotein 5 of PRRSV"]}]}],"canonical_facts":{"dc:creator":["Eaton, Michael"],"dc:date.available":["2024-11-08T08:00:00Z"],"dc:date.created":["2006-01-01T08:00:00Z"],"dc:description.abstract":["In previous studies, we have shown that plasmid DNA priming followed by boosting with a herpes simplex virus (HSV)-1 amplicon vectored human immunodeficiency virus (HIV)-1 gp120 antigen induced potent T cell-mediated immunity and antibody response in immunized mice. To evaluate the potential application of this immunotherapeutic approach for porcine reproductive and respiratory syndrome virus (PRRSV) vaccine development, we generated plasmid DNA and a HSV-1 amplicon vector encoding codon-optimized glycoprotein 5 (sGP5) gene of PRRSV. The immunogenicity and protection efficacy of these constructs were evaluated in pigs. Results showed that sGp5 specific, interferon-gamma secreting CD4 T cells and antibody responses were induced via the DNA prime/amplicon boost regimen. Increases in CD4 T cell immunity and antibody responses were observed following challenge of animals with PRRSV, indicative of a memory immune response elicited by the vaccination. However, no PRRSV-specific neutralization (VN) antibody was detected after the boosting immunization, although a subset of animals developed VN antibody following virus challenge with titers ranging from 1 :4 to l: 16. Furthermore, viral RNA was detected in the sera of all animals at 10 days after challenge. Overall, HSV-1 amplicon-vectored PRRSV sGp5 induced PRRSV-specific T cell and antibody responses in immunized animals, but such immune responses were insufficient to provide protection against viremia of animals after PRRSV challenge."],"dc:identifier":["https://openprairie.sdstate.edu/etd2/1248"],"dc:title":["Immunogenicity and Protection Efficacy of a Herpes Simplex Virus-based Amplicon Vector Expressing Codon-optimized Glycoprotein 5 of PRRSV"],"thesis:degree_discipline":["Biology and Microbiology"],"thesis:degree_level":["Thesis - University Access Only"],"thesis:degree_name":["Master of Science (MS)"]},"updated_at":"2026-11-19T09:04:49Z"}